Clinical Trial Update: A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013

View source ↗

Summary

A retrospective chart review of 33 pediatric patients with immune thrombocytopenia treated with romiplostim or eltrombopag between 2009 and 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Nplate (romiplostim)
• Promacta (eltrombopag)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Immune Thrombocytopenia | Status: COMPLETED